Literature DB >> 11180756

Menstrual Migraine.

Elizabeth Loder1.   

Abstract

Slightly less than half of women with migraine report that menstruation is an important trigger of headache episodes. However, it is rare that menstruation is the only trigger for a patient and its importance as a trigger may be over- emphasized. Accurate diagnosis requires a prospectively kept diary of information showing a consistent and mechanistically valid temporal correlation between migraine attacks and menstrual periods. Abnormal central nervous system response to normal fluctuations in hormones is the likely underlying cause of menstrual migraine. Patients with menstrual migraine do not generally have hormonal abnormalities. Currently available abortive therapy works well for menstrual-related migraine attacks. For the small subset of women for whom this is not the case, and whose menstrual periods and associated headaches are predictable, pre-emptive treatment of the expected headache with scheduled perimenstrual use of a number of agents can be helpful. A hormonal trigger for migraine headache does not mean that treatment must also be hormonal in nature. Choice of therapy depends on the frequency of menstrual migraine, predictability of menstrual periods, patient preference, and cost. For the small group of women with refractory menstrual migraine, hormonal therapy can be tried, with the understanding that the quality of evidence for these interventions is low and their risk to benefit ratios not established. The perimenstrual use of triptan medications is currently being investigated for the treatment of menstrual migraine. Preliminary results are inconclusive, and until further evidence regarding the efficacy, safety, practicality, and cost effectiveness of this approach is available, their routine use in this manner for menstrual migraine is not recommended.

Entities:  

Year:  2001        PMID: 11180756     DOI: 10.1007/s11940-001-0054-1

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  33 in total

1.  Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study.

Authors:  G Sances; E Martignoni; L Fioroni; F Blandini; F Facchinetti; G Nappi
Journal:  Headache       Date:  1990-11       Impact factor: 5.887

2.  Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial.

Authors:  R C Cady; R Ryan; P Jhingran; S O'Quinn; D G Pait
Journal:  Arch Intern Med       Date:  1998-05-11

3.  Prevention of menstrual migraine by percutaneous oestradiol.

Authors:  B de Lignières; M Vincens; P Mauvais-Jarvis; J L Mas; P J Touboul; M G Bousser
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-13

Review 4.  Drug therapy of migraine.

Authors:  K M Welch
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

Review 5.  Menstrual migraine. Methods of prevention and control.

Authors:  I Fettes
Journal:  Postgrad Med       Date:  1997-05       Impact factor: 3.840

6.  Continuous bromocriptine therapy in menstrual migraine.

Authors:  A G Herzog
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

Review 7.  Management of menstrual migraine.

Authors:  C A Boyle
Journal:  Neurology       Date:  1999       Impact factor: 9.910

Review 8.  Sex hormones and headache.

Authors:  S D Silberstein; G R Merriam
Journal:  J Pain Symptom Manage       Date:  1993-02       Impact factor: 3.612

9.  A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.

Authors:  L C Newman; R B Lipton; C L Lay; S Solomon
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

10.  Coronary side-effect potential of current and prospective antimigraine drugs.

Authors:  A MaassenVanDenBrink; M Reekers; W A Bax; M D Ferrari; P R Saxena
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

View more
  3 in total

Review 1.  The use of triptans in the management of menstrual migraine.

Authors:  Lisa K Mannix; Julia A Files
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.

Authors:  Gianni Allais; Vincenzo Tullo; Stefano Omboni; Chiara Benedetto; Grazia Sances; Dario Zava; Michel D Ferrari; Gennaro Bussone
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

3.  Acute migraine: Current treatment and emerging therapies.

Authors:  Arun A Kalra; Debra Elliott
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.